NEW YORK (GenomeWeb News) – Response Genetics today said that its revenues in the third quarter dropped 24 percent year over year as both pharmaceutical client and ResponseDX revenues fell.

The firm's total revenues for the third quarter came in at $4.1 million, down from $5.4 million a year ago. Pharma client revenues decreased 35 percent year over year, the Los Angeles-based molecular diagnostics shop said, adding that ResponseDX revenues were down 16 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.